FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3197212947> ?p ?o ?g. }

• W3197212947 endingPage "1140" @default.
• W3197212947 startingPage "1140" @default.
• W3197212947 abstract "Background and Aims: The increasing prevalence and absence of effective global treatment for metabolic syndrome (MetS) are alarming given the potential progression to severe non-communicable disorders such as type 2 diabetes and nonalcoholic fatty liver disease. The purpose of this study was to investigate the regulatory role of glycomacropeptide (GMP), a powerful milk peptide, in insulin resistance and liver dysmetabolism, two central MetS conditions. Materials and Methods: C57BL/6 male mice were fed a chow (Ctrl), high-fat, high-sucrose (HFHS) diet or HFHS diet along with GMP (200 mg/kg/day) administered by gavage for 12 weeks. Results: GMP lowered plasma insulin levels (in response to oral glucose tolerance test) and HOMA-IR index, indicating a more elevated systemic insulin sensitivity. GMP was also able to decrease oxidative stress and inflammation in the circulation as reflected by the decline of malondialdehyde, F2 isoprostanes and lipopolysaccharide. In the liver, GMP raised the protein expression of the endogenous anti-oxidative enzyme GPx involving the NRF2 signaling pathway. Moreover, the administration of GMP reduced the gene expression of hepatic pro-inflammatory COX-2, TNF-α and IL-6 via inactivation of the TLR4/NF-κB signaling pathway. Finally, GMP improved hepatic insulin sensitization given the modulation of AKT, p38 MAPK and SAPK/JNK activities, thereby restoring liver homeostasis as revealed by enhanced fatty acid β-oxidation, reduced lipogenesis and gluconeogenesis. Conclusions: Our study provides evidence that GMP represents a promising dietary nutraceutical in view of its beneficial regulation of systemic insulin resistance and hepatic insulin signaling pathway, likely via its powerful antioxidant and anti-inflammatory properties." @default.
• W3197212947 created "2021-09-13" @default.
• W3197212947 creator A5000579424 @default.
• W3197212947 creator A5002007191 @default.
• W3197212947 creator A5004278412 @default.
• W3197212947 creator A5007226750 @default.
• W3197212947 creator A5008313325 @default.
• W3197212947 creator A5020808506 @default.
• W3197212947 creator A5025613015 @default.
• W3197212947 creator A5028274475 @default.
• W3197212947 creator A5031307686 @default.
• W3197212947 creator A5037076604 @default.
• W3197212947 creator A5044096349 @default.
• W3197212947 creator A5047467312 @default.
• W3197212947 creator A5069174275 @default.
• W3197212947 date "2021-09-02" @default.
• W3197212947 modified "2023-10-17" @default.
• W3197212947 title "Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations" @default.
• W3197212947 cites W1496181943 @default.
• W3197212947 cites W1749005812 @default.
• W3197212947 cites W1970105405 @default.
• W3197212947 cites W1997404397 @default.
• W3197212947 cites W2015668953 @default.
• W3197212947 cites W2017820712 @default.
• W3197212947 cites W2019734687 @default.
• W3197212947 cites W2037572308 @default.
• W3197212947 cites W2050434504 @default.
• W3197212947 cites W2059815420 @default.
• W3197212947 cites W2060746639 @default.
• W3197212947 cites W2061429720 @default.
• W3197212947 cites W2073128218 @default.
• W3197212947 cites W2102547347 @default.
• W3197212947 cites W2113653640 @default.
• W3197212947 cites W2114928678 @default.
• W3197212947 cites W2129694722 @default.
• W3197212947 cites W2129917444 @default.
• W3197212947 cites W2129924366 @default.
• W3197212947 cites W2154024784 @default.
• W3197212947 cites W2161883681 @default.
• W3197212947 cites W2163187036 @default.
• W3197212947 cites W2204688218 @default.
• W3197212947 cites W2300961054 @default.
• W3197212947 cites W2346688577 @default.
• W3197212947 cites W2479115888 @default.
• W3197212947 cites W2582145734 @default.
• W3197212947 cites W2606513998 @default.
• W3197212947 cites W2625336870 @default.
• W3197212947 cites W2626648542 @default.
• W3197212947 cites W2735527928 @default.
• W3197212947 cites W2736390409 @default.
• W3197212947 cites W2753709051 @default.
• W3197212947 cites W2765151872 @default.
• W3197212947 cites W2767767370 @default.
• W3197212947 cites W2794083325 @default.
• W3197212947 cites W2809802332 @default.
• W3197212947 cites W2886504687 @default.
• W3197212947 cites W2886865853 @default.
• W3197212947 cites W2902086897 @default.
• W3197212947 cites W2913304194 @default.
• W3197212947 cites W2934946727 @default.
• W3197212947 cites W2964727235 @default.
• W3197212947 cites W2995121531 @default.
• W3197212947 cites W2999040935 @default.
• W3197212947 cites W2999643380 @default.
• W3197212947 cites W3011882788 @default.
• W3197212947 cites W3013533220 @default.
• W3197212947 cites W3017920134 @default.
• W3197212947 cites W3037892019 @default.
• W3197212947 cites W3047044606 @default.
• W3197212947 cites W3143409077 @default.
• W3197212947 cites W3158919838 @default.
• W3197212947 cites W3159126691 @default.
• W3197212947 cites W4211112701 @default.
• W3197212947 cites W904205897 @default.
• W3197212947 doi "https://doi.org/10.3390/biomedicines9091140" @default.
• W3197212947 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8469639" @default.
• W3197212947 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34572325" @default.
• W3197212947 hasPublicationYear "2021" @default.
• W3197212947 type Work @default.
• W3197212947 sameAs 3197212947 @default.
• W3197212947 citedByCount "6" @default.
• W3197212947 countsByYear W31972129472022 @default.
• W3197212947 countsByYear W31972129472023 @default.
• W3197212947 crossrefType "journal-article" @default.
• W3197212947 hasAuthorship W3197212947A5000579424 @default.
• W3197212947 hasAuthorship W3197212947A5002007191 @default.
• W3197212947 hasAuthorship W3197212947A5004278412 @default.
• W3197212947 hasAuthorship W3197212947A5007226750 @default.
• W3197212947 hasAuthorship W3197212947A5008313325 @default.
• W3197212947 hasAuthorship W3197212947A5020808506 @default.
• W3197212947 hasAuthorship W3197212947A5025613015 @default.
• W3197212947 hasAuthorship W3197212947A5028274475 @default.
• W3197212947 hasAuthorship W3197212947A5031307686 @default.
• W3197212947 hasAuthorship W3197212947A5037076604 @default.
• W3197212947 hasAuthorship W3197212947A5044096349 @default.
• W3197212947 hasAuthorship W3197212947A5047467312 @default.
• W3197212947 hasAuthorship W3197212947A5069174275 @default.
• W3197212947 hasBestOaLocation W31972129471 @default.

• next